Seeing Is Believing
CTIC is currently covered by 6 analysts with an average price target of $11.23. This is a potential upside of $2.14 (23.54%) from yesterday's end of day stock price of $9.09.
CTi Biopharma Corp's activity chart (see below) currently has 20 price targets and 24 ratings on display. The stock rating distribution of CTIC is 50% BUY and 50% HOLD.
Analysts average stock forecasts to be materialized ratio is 85.71% with an average time for these price targets to be met of 228.71 days.
Highest price target for CTIC is $9, Lowest price target is $4, average price target is $11.23.
Most recent stock forecast was given by RENI BENJAMIN from JMP on 24-May-2023. First documented stock forecast 13-Oct-2020.
Currently out of the existing stock ratings of CTIC, 6 are a BUY (50%), 6 are a HOLD (50%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
1 years 5 months 27 days ago
(24-May-2023)
4/4 (100%)
$4.25 (89.47%)
124
Hold
$9.1
$0.01 (0.11%)
$13
1 years 6 months 4 days ago
(16-May-2023)
1/2 (50%)
$0.19 (2.13%)
36
Hold
$9.1
$0.01 (0.11%)
$8.1
1 years 6 months 5 days ago
(15-May-2023)
2/2 (100%)
$0.17 (1.90%)
51
Hold
$9
1 years 6 months 9 days ago
(11-May-2023)
5/5 (100%)
$3.88 (75.78%)
190
Hold
$9.1
$0.01 (0.11%)
$8
1 years 6 months 10 days ago
(10-May-2023)
2/2 (100%)
$0.17 (1.90%)
491
What is CTIC (CTi Biopharma Corp) average time for price targets to be met?
Which analyst has the current highest performing score on CTIC (CTi Biopharma Corp) with a proven track record?
Which analyst has the current lower performing score on CTIC (CTi Biopharma Corp) with a proven track record?
Which analyst has the most public recommendations on CTIC (CTi Biopharma Corp)?
Which analyst is the currently most bullish on CTIC (CTi Biopharma Corp)?
Which analyst is the currently most reserved on CTIC (CTi Biopharma Corp)?